Search

Author/Creator Asrat, Seblewongel

1. Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation. Issue 5 (3rd January 2020)

Authors:
Le Floc'h, Audrey; Allinne, Jeanne; Nagashima, Kirsten; Scott, George; Birchard, Dylan; Asrat, Seblewongel; Bai, Yu; Lim, Wei Keat; Martin, Joel; Huang, Tammy; Potocky, Terra B.; Kim, Jee H.; Rafique, Ashique; Papadopoulos, Nicholas J.; Stahl, Neil; Yancopoulos, George D.; Murphy, Andrew J.; Slee...
Journal:
Allergy
Issue:
Volume 75:Issue 5(2020)
Page Start:
1188
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline. (February 2023)

Authors:
Scott, George; Asrat, Seblewongel; Allinne, Jeanne; Keat Lim, Wei; Nagashima, Kirsten; Birchard, Dylan; Srivatsan, Subhashini; Ajithdoss, Dharani K.; Oyejide, Adelekan; Ben, Li-Hong; Walls, Johnathon; Le Floc'h, Audrey; Yancopoulos, George D.; Murphy, Andrew J.; Sleeman, Matthew A.; Orengo, Jamie M.
Journal:
Cytokine
Issue:
Volume 162(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search